Brief: Docmorris Confirms Targets For 2024
Oct 15 (Reuters) - DocMorris AG DOCM.S :
* DOCMORRIS ACCELERATES RX GROWTH
* RX REVENUE GROWTH OF 12.2 PER CENT IN Q3
* OTC GROWTH OF 1.9 PER CENT
* PABLO ROS GOMEZ BECOMES NEW CTO
* DOCMORRIS CONFIRMS TARGETS FOR 2024 COMMUNICATED IN AUGUST
* DOCMORRIS WILL CLOSE ITS ZUR ROSE PHARMA GMBH SERVICE
LOCATION
ON 31 DECEMBER 2024
Source text for Eikon: ID:nEQ25vJNya
Further company coverage: DOCM.S
(Gdansk Newsroom)
(((( gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))
Recent news on DocMorris AG
See all newsBrief: Docmorris AG Revenue And Adjusted EBITDA Guidance For 2026 Increased
Swiss stocks - Factors to watch on October 15
Brief: Docmorris Announces Final Conversion Price And Issue Size Of Its New Convertible Bonds Due 2031
Brief: Docmorris Successfully Completes The Private Placement Of Convertible Bonds Due 2031
Brief: Docmorris AG Convertible Bond Books Covered Throughout Bookbuilding Range, Says Bookrunner